More R S, Brack M J, Gershlick A H
Academic Department of Cardiology, Glenfield General Hospital, Leicester, UK.
Clin Cardiol. 1996 May;19(5):393-7. doi: 10.1002/clc.4960190512.
This study was undertaken to determine whether the behavior of angioplasty balloons within coronary arteries may differ from that anticipated from data provided by the manufacturers. In particular, the in vitro pressure-diameter profiles may not truly represent in vivo sizes.
Thus, we assessed the degree of correlation of in vitro with in vivo measurements obtained during routine angioplasty practice. In vivo size of 2.5 mm compliant (n = 8) and 3 mm semicompliant (n = 8) balloons was assessed using quantitative angiography for first, second, and third inflations.
In vivo size was less than expected from in vitro measurements. In general balloon diameter increased with inflation pressures up to 8 atmospheres, and some degree of elastic recoil was evident with both balloon types after the last inflation.
In vivo balloon size may not be accurately predicted from manufacturers' published data. Size is more likely to be affected by factors such as lesion characteristics and elasticity of the vessel wall than by balloon material compliance characteristics.
本研究旨在确定冠状动脉内血管成形术球囊的行为是否可能与制造商提供的数据所预期的不同。特别是,体外压力-直径曲线可能无法真实反映体内尺寸。
因此,我们评估了常规血管成形术实践中体外测量与体内测量的相关程度。使用定量血管造影术对2.5毫米顺应性球囊(n = 8)和3毫米半顺应性球囊(n = 8)进行首次、第二次和第三次充盈,评估其体内尺寸。
体内尺寸小于体外测量预期。一般来说,球囊直径随充气压力增加至8个大气压而增大,两种球囊在最后一次充气后均出现一定程度的弹性回缩。
根据制造商公布的数据可能无法准确预测球囊在体内的尺寸。尺寸更可能受病变特征和血管壁弹性等因素影响,而非球囊材料的顺应性特征。